Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S V Seremetis

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Journal of Gender-Specific Medicine : JGSM : the Official Journal of the Partnership for Women'S Health at Columbia|August 2, 2001
Sex-related differences in hemostasis and thrombosisS V Seremetis
Drugs|April 1, 1993
Congenital bleeding disorders. Rational treatment optionsS V Seremetis, L M Aledort
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Liver failure and mortality in HIV-positive haemophiliacs: FOURTEEN-YEAR EXPERIENCE AND LITERATURE REVIEWJ D Schwartz, L M Aledort, S V Seremetis
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1986
Biochemistry and expression of myelomonocytic antigensS M Goyert, E M Ferrero, S V Seremetis, et al.
Blood|October 1, 1987
HL-T, a new cell line derived from HL-60 promyelocytic leukemia cell cultures expressing terminal transferase and secreting suppressor activityE Paietta, R J Stockert, T Calvelli, et al.
The Journal of Experimental Medicine|June 1, 1987
High frequency of clonal immunoglobulin or T cell receptor gene rearrangements in acute myelogenous leukemia expressing terminal deoxyribonucleotidyltransferaseS V Seremetis, P G Pelicci, A Tabilio, et al.
Lancet (London, England)|September 18, 1993
Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune statusS V Seremetis, L M Aledort, G E Bergman, et al.
Lancet (London, England)|September 17, 1994
Risks of immunodeficiency, AIDS, and death related to purity of factor VIII concentrate. Multicenter Hemophilia Cohort StudyJ J Goedert, A R Cohen, C M Kessler, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of Gender-Specific Medicine : JGSM : the Official Journal of the Partnership for Women'S Health at Columbia|August 2, 2001
Sex-related differences in hemostasis and thrombosisS V Seremetis
Drugs|April 1, 1993
Congenital bleeding disorders. Rational treatment optionsS V Seremetis, L M Aledort
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Liver failure and mortality in HIV-positive haemophiliacs: FOURTEEN-YEAR EXPERIENCE AND LITERATURE REVIEWJ D Schwartz, L M Aledort, S V Seremetis
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1986
Biochemistry and expression of myelomonocytic antigensS M Goyert, E M Ferrero, S V Seremetis, et al.
Blood|October 1, 1987
HL-T, a new cell line derived from HL-60 promyelocytic leukemia cell cultures expressing terminal transferase and secreting suppressor activityE Paietta, R J Stockert, T Calvelli, et al.
The Journal of Experimental Medicine|June 1, 1987
High frequency of clonal immunoglobulin or T cell receptor gene rearrangements in acute myelogenous leukemia expressing terminal deoxyribonucleotidyltransferaseS V Seremetis, P G Pelicci, A Tabilio, et al.
Lancet (London, England)|September 18, 1993
Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune statusS V Seremetis, L M Aledort, G E Bergman, et al.
Lancet (London, England)|September 17, 1994
Risks of immunodeficiency, AIDS, and death related to purity of factor VIII concentrate. Multicenter Hemophilia Cohort StudyJ J Goedert, A R Cohen, C M Kessler, et al.
Pageof 1